Revolution Medicines Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -4,190.4% | – | – | – | – | – | – | |
| – | +48.5% | +89.5% | +95.8% | +12.0% | +31.7% | -3.6% | +27.0% | -328.0% | |
| – | +506.4% | +269.7% | +181.1% | +133.2% | +50.5% | +98.0% | +28.2% | +49.5% | |
| – | +2,153.2% | +11.2% | +140.8% | +180.3% | +18.0% | – | – | – | |
| – | +718.5% | -111.7% | – | – | -254.6% | – | -97.1% | +7,333.5% | |
| – | -4.8% | +72.7% | +13.3% | +122.6% | +65.7% | -28.5% | +33.4% | +55.1% | |
| – | -15.0% | +7,515.3% | +129.7% | -39.3% | -83.0% | +1,320.6% | +61.8% | – | |
| – | -100.6% | -65.6% | – | +125.4% | -0.6% | +78.0% | +51.6% | +59.8% | |
| – | +168.5% | +62.1% | +328.5% | -30.4% | +2.5% | +307.8% | -21.9% | -35.2% | |
| – | – | -187.2% | – | -94.5% | +983.9% | +910.6% | -128.6% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.